Preparation of bacterial vaccines and toxoids MCQs With Answer

Preparation of bacterial vaccines and toxoids covers microbiological, chemical, and pharmaceutical principles essential for B.Pharm students. This topic explores antigen selection, inactivation of pathogens, detoxification of bacterial toxins into toxoids, purification techniques (centrifugation, chromatography, ultrafiltration), formulation with adjuvants, stability and sterility testing, potency assays, and regulatory quality control. Emphasis is placed on practical steps like inactivation kinetics, endotoxin removal, conjugation chemistry for polysaccharide vaccines, cold-chain requirements, and lot-release criteria to ensure safety and immunogenicity. Mastery of these concepts prepares students for vaccine development, manufacturing, and quality assurance in both industry and regulatory settings. Now let’s test your knowledge with 30 MCQs on this topic.

Q1. What is the primary objective of the inactivation step during preparation of killed bacterial vaccines?

  • Eliminate infectivity while preserving antigenic structure
  • Completely remove all nucleic acids
  • Reduce endotoxin to zero
  • Increase reactogenicity to boost immune response

Correct Answer: Eliminate infectivity while preserving antigenic structure

Q2. Which chemical is most commonly used to convert bacterial toxins into toxoids?

  • Formaldehyde
  • Sodium hydroxide
  • Hydrogen peroxide
  • Phenol

Correct Answer: Formaldehyde

Q3. What is the main role of adjuvants in bacterial vaccine formulations?

  • Enhance the immune response to the antigen
  • Sterilize the vaccine during storage
  • Act as a preservative in multi-dose vials
  • Neutralize endotoxin contamination

Correct Answer: Enhance the immune response to the antigen

Q4. Which technique is frequently used for endotoxin removal from protein antigens?

  • Triton X-114 phase separation
  • Nitrocellulose filtration
  • Dialysis against water alone
  • Clotting with alum

Correct Answer: Triton X-114 phase separation

Q5. What defines a conjugate bacterial vaccine?

  • Polysaccharide antigen covalently linked to a protein carrier
  • Live attenuated bacteria given with adjuvant
  • Inactivated whole-cell bacterium with toxoid
  • DNA encoding bacterial antigens encapsulated in lipid

Correct Answer: Polysaccharide antigen covalently linked to a protein carrier

Q6. Which stability testing approach assesses vaccine shelf-life by accelerated conditions?

  • Accelerated stability testing at elevated temperature
  • Only real-time long-term storage testing
  • Immediate post-manufacture potency test
  • Freeze–thaw cycle ignored testing

Correct Answer: Accelerated stability testing at elevated temperature

Q7. Which methods are accepted pharmacopeial approaches for sterility testing of vaccines?

  • Membrane filtration and direct inoculation methods
  • Only ATP bioluminescence
  • Visual turbidity inspection alone
  • Endotoxin assay (LAL) alone

Correct Answer: Membrane filtration and direct inoculation methods

Q8. Which assay is traditionally used to quantify residual formaldehyde in toxoid preparations?

  • Colorimetric assay (chromotropic acid)
  • Limulus amebocyte lysate (LAL) assay
  • Bradford protein assay
  • Hemagglutination assay

Correct Answer: Colorimetric assay (chromotropic acid)

Q9. Why is lyophilization used in some bacterial vaccine formulations?

  • To improve long-term stability and shelf life
  • To increase the vaccine’s viscosity for injection
  • To remove all antigenicity before packaging
  • To sterilize the product by freezing

Correct Answer: To improve long-term stability and shelf life

Q10. Which test best assesses functional potency of a toxoid vaccine?

  • In vivo potency testing in animal models
  • Purely in vitro endotoxin quantification
  • Visual color change stability test
  • pH measurement only

Correct Answer: In vivo potency testing in animal models

Q11. Which carrier protein is widely used for conjugate bacterial vaccines?

  • CRM197 (nontoxic diphtheria mutant)
  • Ovalbumin
  • Human serum albumin
  • Pepsin

Correct Answer: CRM197 (nontoxic diphtheria mutant)

Q12. The inactivation of bacteria by chemical agents often follows which kinetic model?

  • First-order kinetics
  • Zero-order kinetics
  • Sigmoidal growth kinetics
  • Michaelis–Menten kinetics

Correct Answer: First-order kinetics

Q13. Adsorption of antigens onto aluminum salts largely depends on which interaction?

  • Electrostatic adsorption
  • Covalent bonding
  • Hydrophobic partitioning only
  • Enzymatic cross-linking

Correct Answer: Electrostatic adsorption

Q14. Which of the following is a critical quality attribute for vaccine lot release?

  • Potency, sterility, purity and identity
  • Color alone
  • Manufacturing line operator name
  • Formulation syringe size only

Correct Answer: Potency, sterility, purity and identity

Q15. Which chromatographic technique is commonly used to fractionate bacterial proteins during purification?

  • Ion-exchange chromatography
  • Gas chromatography
  • Thin-layer chromatography
  • Paper chromatography

Correct Answer: Ion-exchange chromatography

Q16. How are live bacterial vaccines typically attenuated for safety?

  • Serial passage in non-native hosts or cell lines to reduce virulence
  • Exposure to ultraviolet light to cross-link DNA permanently
  • Mixing with formaldehyde at high concentration to kill them
  • Encapsulation in lipids to conceal pathogenicity

Correct Answer: Serial passage in non-native hosts or cell lines to reduce virulence

Q17. Why are preservatives used in multi-dose vaccine vials?

  • To prevent microbial growth after repeated needle entries
  • To stabilize antigen tertiary structure at high temperature
  • To decrease viscosity for faster injection
  • To neutralize aluminum adjuvant

Correct Answer: To prevent microbial growth after repeated needle entries

Q18. Which assay specifically detects bacterial endotoxin contamination in vaccine preparations?

  • Limulus amebocyte lysate (LAL) assay
  • Bradford protein assay
  • ELISA for IgG
  • PCR for bacterial DNA

Correct Answer: Limulus amebocyte lysate (LAL) assay

Q19. At what temperature range are most bacterial toxoid vaccines stored?

  • 2–8°C (refrigerated)
  • -20°C to -80°C (ultra-cold)
  • Room temperature (20–25°C)
  • Above 30°C

Correct Answer: 2–8°C (refrigerated)

Q20. Which regulatory guidance is most relevant for global vaccine manufacturing standards?

  • WHO guidelines and national pharmacopeias
  • Local hospital protocols only
  • US EPA drinking water standards
  • Cosmetic ingredient monographs

Correct Answer: WHO guidelines and national pharmacopeias

Q21. What is a toxoid?

  • An inactivated bacterial toxin that retains antigenicity
  • A live attenuated toxigenic bacterium
  • An endotoxin-free protein fragment
  • A lipid formulation used as an adjuvant

Correct Answer: An inactivated bacterial toxin that retains antigenicity

Q22. Which contaminant is a particular concern when processing Gram-negative bacterial antigens?

  • Endotoxin (lipopolysaccharide, LPS)
  • Mycolic acids
  • Teichoic acids only found in viruses
  • Capsular polysaccharide exclusively in fungi

Correct Answer: Endotoxin (lipopolysaccharide, LPS)

Q23. What is a major mechanism by which aluminum adjuvants enhance immune responses?

  • Depot formation and stimulation of innate immunity
  • Direct DNA incorporation into host cells
  • Enzymatic activation of antigen cleavage
  • Permanent covalent modification of antigen epitopes

Correct Answer: Depot formation and stimulation of innate immunity

Q24. Which laboratory method is commonly used to quantify specific antigen content in a vaccine formulation?

  • Enzyme-linked immunosorbent assay (ELISA)
  • Gram staining
  • pH titration
  • Optical density at 600 nm for bacterial growth

Correct Answer: Enzyme-linked immunosorbent assay (ELISA)

Q25. What is the main purpose of buffer exchange or diafiltration during vaccine downstream processing?

  • Remove small molecule impurities and transfer antigen into final formulation buffer
  • Increase antigen molecular weight
  • Create covalent bonds between antigens and adjuvants
  • Sterilize the product by filtration through 0.45 μm only

Correct Answer: Remove small molecule impurities and transfer antigen into final formulation buffer

Q26. Which cell disruption method is commonly used at industrial scale to release intracellular bacterial antigens?

  • High-pressure homogenization
  • Manual grinding with mortar and pestle
  • Simple vortexing for 1 minute
  • Low-speed stirring only

Correct Answer: High-pressure homogenization

Q27. During vaccine filling operations, what is the most critical manufacturing control?

  • Aseptic conditions to prevent contamination
  • Use of colored vials for branding
  • Filling at room humidity above 80%
  • Allowing open-air filling to speed up process

Correct Answer: Aseptic conditions to prevent contamination

Q28. Which assay is commonly used to quantify residual protein concentration in vaccine intermediates?

  • BCA protein assay
  • Silver nitrate staining of lipids
  • pH meter reading
  • ATP luminescence assay only

Correct Answer: BCA protein assay

Q29. Which in vitro test is increasingly used to assess pyrogenicity of vaccine batches instead of the rabbit pyrogen test?

  • Monocyte activation test (in vitro)
  • Mouse protection test only
  • Standard hemagglutination inhibition test
  • Colorimetric Bradford assay

Correct Answer: Monocyte activation test (in vitro)

Q30. Which chemical coupling reagent is commonly used to conjugate polysaccharides to carrier proteins?

  • Carbodiimide (e.g., EDC) coupling chemistry
  • SDS-mediated non-covalent adsorption
  • Hydrazine gas fumigation
  • Ultraviolet cross-linking without reagents

Correct Answer: Carbodiimide (e.g., EDC) coupling chemistry

Author

  • G S Sachin
    : Author

    G S Sachin is a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. He holds a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research and creates clear, accurate educational content on pharmacology, drug mechanisms of action, pharmacist learning, and GPAT exam preparation.

    Mail- Sachin@pharmacyfreak.com

Leave a Comment

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators